C5 and chronic inflammatory demyelinating polyradiculoneuropathy: CIDP patients with higher disability at the time of diagnosis tended to have higher serum C5a and soluble TCC levels; these levels reduced and significantly correlated with the reduction in INCAT scores at the week 4 follow-up visit after initiation of IVIg treatment.